D
Crinetics Pharmaceuticals, Inc. CRNX
$34.47 -$0.57-1.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -80.60M -76.83M -74.06M -66.93M -60.10M
Total Depreciation and Amortization 788.00K 770.00K 753.00K 474.00K 262.00K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 15.44M 15.39M 16.28M 10.91M 13.02M
Change in Net Operating Assets -308.00K -2.15M 11.40M 2.69M 8.30M
Cash from Operations -64.67M -62.82M -45.62M -52.86M -38.52M
Capital Expenditure -1.03M -528.00K -955.00K -1.33M -935.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -541.06M 21.13M -52.69M 1.64M -86.37M
Cash from Investing -542.09M 20.60M -53.64M 309.00K -87.31M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 586.18M 58.83M 5.48M 409.38M 38.86M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -32.14M -1.50M 14.00K -15.81M -935.00K
Cash from Financing 554.04M 57.33M 5.50M 393.57M 37.93M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -52.72M 15.11M -93.76M 341.03M -87.90M
Weiss Ratings